A1AG1 Polyclonal Antibody, 20ul Oligo Pool At least 4 complementation groups

At least 4 complementation groups have been identified in B-cell lines established from patients with BLS

referred to as the 11S regulator or PA28

juvenile myelomonocytic leukemia and Watson syndrome

anaphylaxis and allergic rhinitis

SPZ1 may serve as a target for Ras-induced tumor treatments

A1AG1 Polyclonal Antibody, 20ul Oligo Pool At least 4 complementation groupsThis gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation this protein is classified as an acute phase reactant. The specific function of this protein has not yet been determined; however it may be involved in aspects of immunosuppression.